| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af24e5b157d74cd961d654272c9198b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adfaa1c318433b1531d1dc8a297038dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58f4b08c22260bfd8b361aa8be92f39c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_335a050372511d4a6f6e9711444ba7d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1f3858868db48ec70d7ff5d3f8d9374 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94 |
| filingDate |
2008-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0949c6a2f40f9caf668427c16239bb43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfcb3cb83f08f6da037af0d36a91cd7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b7bdc2e715045a40fb8d4aa471b1b17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eadb20cafa8d152491e8a310552c941e |
| publicationDate |
2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009025873-A3 |
| titleOfInvention |
Processes for the preparation of crystalline forms a, b and pure crystalline form a of erlotinib hcl |
| abstract |
The invention provides processes for preparing crystalline Forms A, B and pure crystalline Form A of Erlotinib hydrochloride. |
| priorityDate |
2007-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |